JY
HRMY icon

Jeff Yass’s Harmony Biosciences HRMY Stock Holding History

Jeff Yass’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.36M Buy
147,176
+121,775
+479% +$3.84M ﹤0.01% 4476
2026
Q1 		$711K Buy
25,401
+18,098
+248% +$593K ﹤0.01% 8779
2025
Q4 		$273K Sell
7,303
-38,664
-84% -$1.27M ﹤0.01% 10162
2025
Q3 		$1.27M Sell
45,967
-28,614
-38% -$986K ﹤0.01% 6768
2025
Q2 		$2.36M Buy
74,581
+12,036
+19% +$387K ﹤0.01% 5444
2025
Q1 		$2.08M Buy
62,545
+44,216
+241% +$1.59M ﹤0.01% 5455
2024
Q4 		$631K Buy
+18,329
New +$630K ﹤0.01% 8102
2024
Q3 		– Sell
-26,306
Closed -$924K – 12420
2024
Q2 		$794K Buy
+26,306
New +$791K ﹤0.01% 7128
2024
Q1 		– Sell
-9,793
Closed -$314K – 12657
2023
Q4 		$316K Sell
9,793
-26,504
-73% -$740K ﹤0.01% 9722
2023
Q3 		$1.19M Buy
36,297
+1,652
+5% +$57.4K ﹤0.01% 6245
2023
Q2 		$1.22M Buy
34,645
+16,756
+94% +$578K ﹤0.01% 6230
2023
Q1 		$584K Buy
+17,889
New +$815K ﹤0.01% 8196
2022
Q4 		– Sell
-12,994
Closed -$714K – 12942
2022
Q3 		$576K Buy
12,994
+5,483
+73% +$267K ﹤0.01% 8108
2022
Q2 		$366K Buy
7,511
+2,421
+48% +$109K ﹤0.01% 9016
2022
Q1 		$248K Sell
5,090
-2,286
-31% -$93.2K ﹤0.01% 10737
2021
Q4 		$315K Buy
+7,376
New +$294K ﹤0.01% 10376
2021
Q2 		– Sell
-13,801
Closed -$456K – 12842
2021
Q1 		$456K Buy
+13,801
New +$484K ﹤0.01% 9697

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's HRMY Position: Q2 2026 in Review

Jeff Yass increased its Harmony Biosciences (HRMY) stake by 479% in Q2 2026, buying an estimated $3.84M and bringing the position to 147,176 shares worth $5.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4476.

Jeff Yass first reported a position in HRMY in Q1 2021 and has held it in 17 quarters since. 325 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jeff Yass held 147,176 shares of Harmony Biosciences worth $5.36M as of Q2 2026.
  • Jeff Yass bought 121,775 Harmony Biosciences shares in Q2 2026, an estimated $3.84M.
  • Harmony Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4476 holding.
  • Jeff Yass first reported a position in Harmony Biosciences in Q1 2021 and has held it in 17 quarters since.
  • 325 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.